All articles by William Newton
William Newton is a Senior Reporter for Clinical Trials Arena and Pharmaceutical Technology, focusing on clinical trial design, healthcare business and regulation, and new technologies. Now based in New York City, he previously covered diabetes drug development at Close Concerns’ industry-facing publication in San Francisco. William holds a BA in Economics from Williams College.

William Newton
@WillNewton19
WHO declares end of Covid-19 public health emergency
The WHO ended the public health emergency for Covid-19 as the pharma industry continues to invest heavily in antiviral drug development.